ARIPIPRAZOLE-AU aripiprazole 5 mg tablet bottle

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

aripiprazole, Quantity: 5 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

aripiprazole

forme pharmaceutique:

Tablet, uncoated

Composition:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; magnesium stearate; maize starch; hyprolose

Mode d'administration:

Oral

Unités en paquet:

100, 250

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Descriptif du produit:

Visual Identification: 5 mm, round, biconvex, white uncoated tablets with 5 debossed on one side and ZL on the other side; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-10-29